Companies / Healthcare / BAX
Baxter International Inc (BAX)
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Ticker BAX Exchange NYSE Sector Healthcare Industry Medical Instruments & Supplies Market cap $13.52B 52-week range $15.73 - $30.00
Valuation Share price $26.16 (close of Nov 18, 2026) P/E (TTM) -18.29x Price to book 2.09x Price to free cash flow 12.00x Enterprise value $20.36B Book value per share $12.52
Price performance Period Change 1 day +1.55% 5 days -0.68% 1 month +3.48% 3 months +0.85% 6 months +47.05% Year to date +36.89% 1 year +44.13% 3 years -26.23% 5 years -66.93% 10 years -44.32% All time +578.74%
Short interest As of Oct 30, 2026 Short % of float 7.22% Shares short 23.67M Days to cover 3.00 Change since prior report -0.38% Source FINRA consolidated short interest
Members of Congress who disclosed BAX trades Lisa McClain · Robert Bresnahan
Super investors holding BAX Richard Pzena (Pzena Investment Management) · Dodge & Cox (Dodge & Cox Funds) · Greenhaven Associates (Greenhaven Associates Inc) · First Pacific Advisors (First Pacific Advisors, LP) · Ken Griffin (Citadel) · Robert Olstein (Olstein Capital Management) · Hillman Capital (Hillman Capital Management, Inc) · Ray Dalio (Bridgewater Associates) · Mairs & Power (Mairs & Power Inc) · Tweedy Browne (Tweedy Browne Company LLC)
Profitability and growth Return on equity -15.68% Return on invested capital -1.94% Return on assets -4.77% Return on capital employed -1.80% Gross margin 30.05% Net margin -8.51% EBITDA margin 5.99% Revenue growth 5.72% Free cash flow growth -42.06%
Cash flow and balance sheet Free cash flow yield (TTM) 8.33% Current ratio 1.79x Net debt to EBITDA 6.41x
Latest reported year Period end Dec 31, 2025 Fiscal year 2025 Revenue $11.24B Cost of revenue $7.87B Gross profit $3.38B EBITDA $673.00M Net income -$957.00M Earnings per share $-1.87 Research and development $518.00M Interest expense $290.00M Shares outstanding 513.00M
Income statement by year Period end Revenue Gross profit Net income EPS 2025-12-31 $11.24B $3.38B -$957.00M -$1.87 2024-12-31 $10.64B $3.98B -$649.00M -$1.27 2023-12-31 $10.36B $4.15B $2.66B $5.25 2022-12-31 $10.06B $3.55B -$2.43B -$4.83 2021-12-31 $12.15B $4.72B $1.28B $2.56 2020-12-31 $11.67B $4.59B $1.10B $2.17 2019-12-31 $11.36B $4.76B $1.00B $1.97 2018-12-31 $11.10B $4.76B $1.55B $2.90 2017-12-31 $10.58B $4.47B $602.00M $1.11 2016-12-31 $10.16B $4.12B $4.96B $9.09
Margins and returns by year Period end Gross margin Net margin Return on equity Return on capital 2025-12-31 30.05% -8.51% -15.68% -1.94% 2024-12-31 37.46% -6.10% -9.24% 0.03% 2023-12-31 40.06% 25.64% 31.37% 2.86% 2022-12-31 35.29% -24.19% -41.27% -11.73% 2021-12-31 38.86% 10.57% 14.08% 4.54% 2020-12-31 39.30% 9.44% 12.63% 8.98% 2019-12-31 41.90% 8.81% 12.65% 13.07% 2018-12-31 42.88% 13.93% 19.65% 13.38% 2017-12-31 42.27% 5.69% 6.61% 6.31% 2016-12-31 40.50% 48.85% 60.39% 6.77%
Cash and debt by year Period end Cash Debt 2025-12-31 $1.97B $9.44B 2024-12-31 $1.76B $13.18B 2023-12-31 $3.08B $13.86B 2022-12-31 $1.62B $16.70B 2021-12-31 $2.95B $17.75B 2020-12-31 $3.73B $6.23B 2019-12-31 $3.33B $4.81B 2018-12-31 $1.84B $3.48B 2017-12-31 $3.39B $3.51B 2016-12-31 $2.80B $2.78B
Free cash flow by year Period end Free cash flow Stock-based compensation 2025-12-31 $332.00M $117.00M 2024-12-31 $573.00M $114.00M 2023-12-31 $1.29B $115.00M 2022-12-31 $834.00M $140.00M 2021-12-31 $1.53B $146.00M 2020-12-31 $1.16B $130.00M 2019-12-31 $1.41B $122.00M 2018-12-31 $1.36B $115.00M 2017-12-31 $1.10B $107.00M 2016-12-31 $935.00M $115.00M
Dividend history Most recent payment Aug 28, 2026 Paid in the last twelve months $0.04 Payment date Dividend per share 2026-08-28 $0.01 2026-05-29 $0.01 2026-02-27 $0.01 2025-11-28 $0.01 2025-08-29 $0.17 2025-05-30 $0.17 2025-02-28 $0.17 2024-11-29 $0.17
Investor relations Past earnings dates Reported Fiscal period EPS estimate 2026-10-29 Sep 2026 $0.51 2026-07-30 Jun 2026 $0.36 2026-04-30 Mar 2026 $0.31 2026-02-12 Dec 2025 $0.53 2025-10-30 Sep 2025 $0.60 2025-07-31 Jun 2025 $0.60 2025-05-01 Mar 2025 $0.48 2025-02-20 Dec 2024 $0.52
Filings and sources Company website baxter.com SEC filings 10-K, 10-Q and 8-K on EDGAR Earnings calendar All upcoming reports
Similar companies Avantor, Inc. (AVTR) · Solventum Corp (SOLV) · Cooper Companies, Inc. (COO) · West Pharmaceutical Services Inc (WST) · Align Technology Inc (ALGN) · Alcon Inc (ALC) · Repligen Corp (RGEN) · ResMed Inc (RMD)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades